Compass Therapeutics (CMPX) Stock Price
Compass Therapeutics Price
Compass Therapeutics stock price
Compass Therapeutics business model & stock analysis
Frequently asked questions about Compass Therapeutics
21 analysts currently rate the Compass Therapeutics stock: 19 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Compass Therapeutics to generate revenue of 39.32 M USD and earnings per share of -0.48 USD.
Converted at the current exchange rate, the Compass Therapeutics share trades at 0.91 EUR (1.02 USD).
The Compass Therapeutics share (CMPX) is listed on 1 stock exchanges, including: NASDAQ (CMPX).
The expected revenue of Compass Therapeutics is 39.32 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Compass Therapeutics is -88.22 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Compass Therapeutics is currently -2.14. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Compass Therapeutics stock.
The price-to-sales ratio (P/S) of Compass Therapeutics is currently 4.80. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Compass Therapeutics stock.
The Eulerpool Quality Score for Compass Therapeutics is 2/10.
The ISIN of Compass Therapeutics is US20454B1044. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Compass Therapeutics is CMPX. The ticker symbol is used to trade Compass Therapeutics shares on the stock exchange.
Compass Therapeutics stock
Compass Therapeutics Peer Group
Compass Therapeutics Ticker
Compass Therapeutics FIGI
All fundamentals and in-depth analysis of Compass Therapeutics
Our stock analysis for Compass Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Compass Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.